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This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/).SUMMARYIn this study, we demonstrate a newly derivedmousemodel that supports engraftment of human hematopoietic stem cells (HSCs) in the
absence of irradiation.We cross theNOD.Cg-PrkdcscidIl2rgtm1Wjl/SzJ (NSG) strainwith theC57BL/6J-KitW-41J/J (C57BL/6.KitW41) strain and
engraft, without irradiation, the resulting NBSGW strain with human cord blood CD34+ cells. At 12-weeks postengraftment in NBSGW
mice, we observe human cell chimerism inmarrow (97% ± 0.4%), peripheral blood (61% ± 2%), and spleen (94% ± 2%) at levels observed
with irradiation inNSGmice.We also detected a significant number of glycophorin-A-positive expressing cells in the developingNBSGW
marrow. Further, the observed levels of human hematopoietic chimerism mimic those reported for both irradiated NSG and NSG-trans-
genic strains. This mouse model permits HSC engraftment while avoiding the complicating hematopoietic, gastrointestinal, and
neurological side effects associated with irradiation and allows investigators without access to radiation to pursue engraftment studies
with human HSCs.INTRODUCTION
The NOD.SCID Il2rg/ (NSG) mouse strain dramatically
improved investigators’ ability to study humanhematopoi-
etic stem cell (HSC) engraftment (Rongvaux et al., 2013;
Shultz et al., 2005). TheNSG strain combines a series ofmu-
tations that inhibit the host’s immune system by different
mechanisms (Bosma et al., 1983; Cao et al., 1995; Greiner
et al., 1995; Ohbo et al., 1996; Shultz et al., 1995). The
NSG and other host strains require myeloablative con-
ditioning (i.e., radiation) to achieve high levels of human
chimerism (McDermott et al., 2010; Shultz et al., 2005).
In addition to the effects of irradiation on the hematopoiet-
ic system that can promote engraftment (Broudy, 1997),
confounding side effects of irradiation, including necrosis
and apoptosis of gastrointestinal, neural, and muscle tis-
sues, can lead to wasting, infection, and even death (Li
et al., 2004; Qiu et al., 2010). Two recent studies report
limited success in engrafting human HSCs into nonmye-
loablated NSGhosts, but the chimerism achieved in the pe-
ripheral blood was modest (an average of 3% ± 3% and
18.3% ± 13%) (Brehm et al., 2012; Bueno et al., 2010).
ViablemutantKit oncogene (Kit)murine strains support the
engraftment ofmouse hematopoietic cells without host irra-
diation (Wang and Bunting, 2008). The Kit (i.e., c-Kit, stem
cell factor [SCF] receptor) encodes a type Imembraneprotein
in the type III tyrosine kinase growth factor receptor familyStem Cell(Yarden and Ullrich, 1988), which is expressed on hemato-
poietic, melanocyte, neural, and germ cells (Mintz and Rus-
sell, 1957; Poole and Silvers, 1979; Russell, 1979). When its
ligand,SCF,binds toc-Kit, it induces receptorhomodimeriza-
tion and signal transduction (Hsu et al., 1997). The c-Kit is
required for normal hematopoiesis, and viable mutants
most closely resemble aplastic anemia (Geissler et al.,
1981). Mouse hosts with mutations in Kit thus provide a
competitive advantage for WT donor cells and allow the
engraftment of HSCs with reduced or no irradiation (Fleish-
man, 1996;Waskowet al., 2009).Until recently, these strains
have been short-lifespan heterozygotes (e.g., Kit+/Wv),
causing a burden on producing experimental hosts (Cosgun
et al., 2014; Waskow et al., 2009). We demonstrate that
nonirradiated NBSGW mice are similar in chimerism to
that achieved in irradiated NSG (irNSG) mice and that
NBSGWmicealso support the serial transplantationofHSCs.RESULTS
Nonirradiated Xenograft NBSGWMice Show
Increased Chimerism in the Peripheral Blood when
Compared with Non-irNSG Mice and Are Similar to
Irradiated NSG Mice
We outcrossed mice homozygous for the KitW41 allele
with the NSG strain. The resultant F1 triple-heterozygotesReports j Vol. 4 j 171–180 j February 10, 2015 j ª2015 The Authors 171
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Table 1. Observed Percentages of Human CD45+ Cells at
12-Weeks Postxenograft or Serial Transplant in Hematopoietic
Compartments of Nonirradiated Mice
Location Marker (Cell) NSG (%) NBSGW (%)
Peripheral
Blood
CD3+ (lymphoid, T cell) 3.1 ± 2.0 3.3 ± 1.5
CD19+ (lymphoid, B cell) 46.4 ± 3.2 68.4 ± 2.9*
CD11b+ (myeloid) 3.4 ± 1.4 2.5 ± 0.5
CD15+ (Neut, Eos, Mono) 2.4 ± 2.2 1.4 ± 0.2
CD66b+ (Gran) 2.5 ± 1.5 2.1 ± 0.3
Bone Marrow CD3+ (lymphoid, T cell) 3.5 ± 0.5 5.4 ± 1.0
CD19+ (lymphoid, B cell) 86.0 ± 2.0 89.0 ± 1.1
CD19+IgM+ (lymphoid, B cell) 0.3 ± 0.1 0.5 ± 0.1
Spleen CD3+ (lymphoid, T cell) 3.6 ± 1.5 3.0 ± 1.5
CD56low/+ (NKT cell) 0.8 ± 0.3 1.0 ± 0.3
Secondary
Graft
CD3+ (lymphoid, T cell) ND 0.3 ± 0.6
Peripheral
Blood
CD19+ (lymphoid, B cell) ND 87.8 ± 4.6
CD11b+ (myeloid) ND 8.5 ± 6.5
Error is represented by SD (n = 5, *p < 0.01). Eos, eosinophil; Gran, granu-
locyte; Mono, monocyte; ND, not determined; Neut, neutrophil.(Prkdc, Il2rg, Sirpa, KitW41) were intercrossed and genotyped
by Sanger sequencing for homozygotes of all four alleles
(NBSGW). Nonalbino NBSGW mice displayed a Holstein
coat with a prominent white stripe down the center of
their head (Figure 1A). However, the NSG strain’s albino
coat color was inherited in 25% of the F2 progeny, making
Kit status difficult to visually determine. To generate a
strain devoid of albino animals and to allow for visual phe-
notyping for Kit status during the establishment of the
strain, we selected for mice genotyping homozygous WT
at the Tyrosinase allele (Shibahara et al., 1990). Albino an-
imals were absent from future generations.
To determine whether the homozygous KitW41 allele
would enhance human hematopoietic chimerism, we
intravenously injected 2.53 105 humanCD34+ cord bloodFigure 1. Nonirradiated NOD,B6.Prkdcscid Il2rgtm1Wjl/SzJ KitW41/W
Exhibit High Levels of Human Chimerism in the Absence of Irradi
(A) An NBSGW mouse.
(B) Experimental design of nonirradiation comparisons.
(C) Representative flow cytometry plots of non-irNSG and NBSGW mice
(D and E) Biweekly monitoring of the human chimerism in the peripher
(n = 3 and n = 5, *p < 0.01, **p < 0.05).
(F) Experimental design of irNSG versus nonirradiated NBSGW.
(G) Monthly monitoring comparison of the human chimerism in peri
represented by SD, n = 3, comparison only, not significant.
Stem Cellcells (CBCs) into the retro-orbital sinus of non-irNSG and
NBSGW 8- to 10-week-old mice (Figure 1B). Every other
week, peripheral blood was drawn and analyzed via flow
cytometry for the presence of human and mouse blood
cell surface proteins (Figure 1C). In two independent exper-
iments (experiment 1, n = 3, Figure 1D; experiment 2, n = 5;
Figure 1E) and at each independent time point, the
NBSGW strain engrafted at higher levels than the NSG
strain. At the 12-week time point, the average percentage
of human chimerism observed in the NBSGW strain
(61% ± 2%) measured 9-fold higher when compared with
the parental control NSG strain (8.3% ± 1.2%; Figures 1D
and 1E).
Both T cells (CD3+) and myeloid (CD11b+, CD15+,
CD66b+) cells represented a similar percentage of human
cells in both NSG and NBSGW hosts (Table 1). However,
the percentage of B cells was significantly increased in the
NBSGW strain (68.4% ± 2.9%) compared with the NSG
strain (46.4% ± 3.2%, p < 0.01).
We performed a separate experiment to investigate how
comparable NBSGWmice are to the field’s standard model:
irNSGmice (Figure 1F). As described above, we injected 2.5
3 105 human CD34+ CBCs into the retro-orbital sinus
of the hosts and assessed the peripheral blood monthly
for presence of human cells by flow cytometry. At the
12-week time point, both strains xenografted similarly
indicating that genetic myeloablation may be similar to
irradiating hosts (n = 3; Figure 1G).NBSGWMouseMarrow Contains Lymphoid, Myeloid,
and Erythroid Human Cells
At 12-weeks postengraftment, the NBSGW strain had a
higher percentage of human cells in the bone marrow
(97% ± 0.4%) compared with the NSG strain (30% ± 9%;
p < 0.01; Figures 2A and 2B). In addition, this corresponded
to a higher percentage of human CD34+ in NBSGW
marrow (18.6% ± 2.5%) compared with NSG marrow
(6.4% ± 1.7%; Figures 2C and 2D available online). Glyco-
phorin A (GlyA) analysis revealed a substantial presence of
human erythroid cells in NBSGWmarrow (26.4% ± 10.4%;
Figures 2F and 2G), but not in NSG marrow (0.12% ±
0.04%). Further analysis of the hosts’ peripheral blood41 (NBSGW) Mice Are Similar to Their irNSG Counterparts and
ation
12-weeks postengraftment and analysis of mouse and human CD45.
al blood of non-irNSG and of NBSGWmice. Error is represented by SD
pheral blood of irNSG and of nonirradiated NBSGW strains. Error is
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did not reveal GlyA+ cells in circulation (data not shown).
Furthermore, myeloid cells were present at a higher level in
NBSGWmarrow (Figure 2E), whereas human Tcells (CD3+)
and B cells (CD19+) in the bone marrow were at similar
levels in both strains (Table 1).Serial Transplantation and Normal HSC Development
Occurs in the NBSGW Strain
To demonstrate effective development of long-term recon-
stituting HSCs in NBSGW marrow, we performed serial
transplantation of HSCs. The primary NBSGW recipient
received an injection of 2.5 3 105 human CD34+ CBCs
into the retro-orbital sinus (Figure 2H). At 16-weeks postxe-
notransplant, we assessed the primary recipientmarrow for
long-term reconstituting human cells by flow cytometry.
We identified a population of human LinCD34+CD38
CD90+CD45RA cells in murine marrow, indicating
that normal hematopoietic development was occurring
in the NBSGW host (Figure 2I). We performed transplants
of humanized marrow to secondary recipients (n = 4) and
assessed the recipients’ peripheral blood for de novo pro-
duced human cells. At both 6 and 12 weeks postengraft-
ment, we observed human cells in the peripheral blood.
At 12 weeks, 2.1% ± 1.0% of the leukocytes stained positive
for human CD45 (Figure 2J). This trend increased from 6
to 12 weeks, indicating an expansion of the secondary
graft. In addition, we observed multilineage reconstitution
of the recipient with both lymphoid and myeloid com-
ponents indicating successful secondary transplantation
(Table 1).Lymphoid Organs of Humanized NBSGW Mice
Reconstitute with Human Cells and Begin to
Recapitulate Immunocompetent Architecture
The spleen-to-bodyweight ratios fromnonengrafted control
NBSGW and NSG mice were, on average, six times smaller
compared with those from immunocompetent C57BL/6J
mice (Figure 3D) and lacked white lymphocyte pulp (Fig-Figure 2. Xenotransplanted Nonirradiated NBSGW Mice Exhibit Inc
Transplantation
(A) The percentage of observed human CD45+ leukocytes in the bone
postengraftment.
(B) Representative mouse CD45 versus human CD45 12-week flow cyt
(C) The observed percentages of human CD34+ cells in the human CD
(D) Representative flow cytometry analysis plot comparison between
(E) The observed percentages of human CD33+ cells observed in the hum
(F) The observed percentage of human GlyA+ cells observed in the m
(G) Representative flow cytometry analysis plot comparison between
(H) Experimental design of nonirradiation NBSGW serial transplantat
(I) Representative flow cytometry analysis of CD34 enriched LinCD3
16 weeks.
(J) Observed human chimerism at both 6 and 12 weeks in secondary
Stem Cellure 3F). Xenografted NBSGW spleens almost tripled in size
comparedwith their unengraftedNBSGWcounterparts (Fig-
ure 3D) and had a restored white pulp (Figure 3F). Interest-
ingly, on average, nonengrafted NBSGW spleens are smaller
than spleens of the NSG strain (Figure 3F).
At 12-weeks postinjection, 94% ± 2% of the splenocytes
in NBSGW were huCD45+ compared with 55% ± 13% in
NSG spleens (Figure 3A). In agreementwith the flowcytom-
etry data, ahuCD45 staining of NBSGW spleen histological
sections revealed more extensive staining than those of
NSG spleens (Figure 3E). We also observed increased stain-
ing of NBSGW spleen sections for both myeloid (CD11b)
and dendritic cells (CD1a) comparedwithNSG spleens (Fig-
ure 3E). Although the level of chimerism overall was higher
in the NBSGW spleen, the percentage of the human cells
that were T cells, natural killer T cells, and B cells was
roughly similar in both strains (Table 1; Figure 3B). Analysis
of the transitional CD19+ population signified a normal B
cell maturation repertoire occurring in both strains of
mice. Of the huCD45+CD19+ cells, 53% ± 3% stained posi-
tively for IgM in the NSG strain compared with 61% ± 4%
in the NBSGW strain (Figure 3C; p = 0.013).
Thymuses were obtained from nonirradiated NBSGW
mice (seven of eight), but we were unsuccessful in defini-
tively identifying like thymic tissue in non-irNSG mice
(zero of eight). This made a technical comparison chal-
lenging. However, we evaluated the NBSGW for both hu-
man MHCII and human CD3. The analysis indicated that
thymuses were low in staining for human MHCII, yet
CD3 staining was found to be in abundance within the tis-
sue (Figure 3G). Further, analysis indicated a lack of thymic
structure with a very disorganized cortex and nonexistent
medulla.DISCUSSION
In this study, we generated mice homozygous for Prkdcscid,
Il2rg/, KitW41, and NOD Sirpa alleles and showed thatreased Humanization in the Marrow and Are Conducive to Serial
marrow of non-irNSG (white) and NBSGW (gray) mice at 12-weeks
ometry plot comparison between non-irNSG and NBSGW mice.
45+ fraction of the mouse marrow (NSG, white; NBSGW, gray).
non-irNSG and NBSGW mice.
an CD45+ fraction of the mouse marrow (NSG, white; NBSGW, gray).
ouse marrow (NSG, white; NBSGW, gray).
non-irNSG and NBSGW mice.
ion.
4+CD38CD90+CD45RA cells isolated from the NBSGW marrow at
NBSGW recipients. (Error is represented by SD, *p < 0.01).
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Figure 3. Human Chimerism, Lineage Development and Gross Pathology Observed in Lymphoid Organs of Non-irNSG (White) and
NBSGW (Gray) Mice at 12-Weeks Postengraftment
(A) The percentage of human CD45+ splenocytes (non-irNSG [white] and NBSGW [gray]).
(B and C) The percentage of human (B) CD19+ cells and (C) CD19+IgM+ cells observed in the human CD45+ fraction.
(legend continued on next page)
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the resultant NBSGW model supports robust levels of hu-
manization in peripheral blood, bone marrow, and spleen
in the absence of irradiation. The observed levels of de
novo derived human HSCs in NBSGW mice are signifi-
cantly higher than the values previously reported for un-
conditioned NSG or NSG-transgenic mice (Brehm et al.,
2012; Bueno et al., 2010). In our studies, the uncondi-
tioned NBSGW strain supported levels of human chime-
rism in peripheral blood that was 9-fold higher (average
61% versus 8.3%) compared with the unconditioned
NSG strain. Furthermore, these levels are equivalent to
those recently reported in multiple irradiated Rag2/
Il2g/ mice possessing humanized loci for TPO, CSF1,
IL3, and CSF2 in which hematopoietic development is
enhanced (Rongvaux et al., 2011, 2014). We further
demonstrate, through serial transplantation, robust
normal development of human HSCs in NBSGW marrow
and the developing HSCs ability to repopulate a secondary
recipient. To our knowledge, KitW41/41mutants when com-
bined with NSG mice yield the highest level of human he-
matopoietic chimerism obtained in any mouse strain
without conditioning by ionizing radiation.
While this manuscript was in review, four Kit mutant
strains on either the BALB/c RAG1/ (BRg KitWv/Wv,
BRgWv) or NSG (NSG KitWv/Wv, NSGWv; NSGWv/+, and
NSGW41) backgrounds were described (Cosgun et al.,
2014). These strains are similar to the NBSGW model
exhibiting comparable humanization potential in the
absence of irradiation. Both BALB/c and NOD immunode-
ficient-based strains support varied types of humanization.
However, NOD background strains have higher humani-
zation potential (Brehm et al., 2010) primarily resulting
from polymorphisms in the Sirpa gene that prevents the
NOD macrophages from engulfing human cells (Takenaka
et al., 2007). Hence, the Kit mutant strains NBSGW,
NSGWv, NSGWv/+, and NSGW41 are better suited recipi-
ents when compared with the BRgWv strain. Homozygous
KitWv NSG mice have a low life expectancy, making the
NSGWv/+ the more useful of the two for long-term exper-
iments (Cosgun et al., 2014). However, genotyping to iden-
tify suitable NSGWv/+ recipients among litters is time
consuming.(D) The ratio of spleen:mouse weight in basal state (unengrafted, n = 4
1, n = 5; experiment 2, n = 3). Error is represented by SD (*p < 0.01)
(E) Representative photomicrographs of sectioned spleens of non-irN
cytometry data). Spleens were stained with anti-human CD45 (spleno
anti-human CD1a (dendritic) and were counterstained with hematoxy
(F) Photomicrographs of hematoxylin (blue) and eosin (red) stained
nonirradiated humanized mice at 12 weeks (right; white scale bar rep
(G) Representative photomicrographs of sectioned thymus from non
MHCII (top), anti-human CD3 (middle), and hematoxylin (blue) and eo
scale bar represents 20 mm).
Stem CellOur goal was to generate a viable homozygous strain
that would engraft with high efficiency without irradia-
tion. Based on previously reported Kit mutant phenotypes
(Geissler et al., 1981), we hypothesized that the KitW41
could be maintained as a homozygous line when crossed
with the NSG, and the contribution of the NSG strain
would boost the efficiency of humanization in the absence
of irradiation. While the NBSGW is a mixed NOD and
C57BL/6J background, the Cosgun strain is a congenic
NOD also incorporating a homozygous KitW41 allele. A
direct comparison of engraftment results between the
two strains is currently difficult due to differences in exper-
imental approaches (e.g., cell numbers and sources) and
reported postengraftment end points (e.g., 12 weeks versus
up to 40 weeks). However, the highest levels of engraft-
ment in the absence of irradiation were observed in homo-
zygous KitW41 immunocompromised mice in both studies,
potentially indicating that a mixed background is inconse-
quential given the correct genetic elements. Based on
these arguments, either the NBSGW or the NSGW41
strains are of choice over their contemporary strains in
the absence of irradiation and may prove as a widely
enabling resource.
In addition to the increased human chimerism in the
blood, we observed a significantly greater percentage of
de novo human erythroid cells in the marrow of NBSGW
mice (average 26.0% versus 0.1%). These levels are 5–12
times higher on average than previous reports with irNSG
mice (Hayakawa et al., 2010;McDermott et al., 2010). How-
ever, our analysis of peripheral blood for GlyA+ cells did
not indicate we had achieved circulating human erythro-
cytes, suggesting that the current mouse model still lacks
signals to complete human erythrogenesis.
TheNBSGWmice exhibit a high degree of human chime-
rism, albeit a bias in differentiation of the engrafted human
hematopoietic cells remains. In normal human peripheral
blood, granulocytes, T cells, and B cells are present at
53%, 20%, and 33%, respectively (Rongvaux et al., 2013),
but within our study, they are present at 2.5%, 3.3%, and
68%, respectively. These biases are comparable to those
previously observed in other mouse xenograft models
(Brehm et al., 2010; Cosgun et al., 2014; McDermott) and two xenograft experiments (C57BL/6J; dark gray, experiment
.
SG and NBSGW mice at 12-weeks postengraftment (based on flow
cyte), anti-human CD19 (B cell), anti-human CD11b (myeloid), and
lin (blue; the black scale bar is 20 mm).
spleens from nonirradiated, nonengrafted mouse strains (left), and
resents 400 mm).
-irradiated NBSGW mice at 12-weeks postengraftment; anti-human
sin (red) stained (bottom; white scale bar represents 400 mm; black
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et al., 2010) and suggest that deficiencies exist in species
cross-reactivity of signaling molecules supporting typical
human hematopoietic cell distributions (Rongvaux et al.,
2013). Additional genetic modifications to NBSGW mice
are possible with the aim of eliminating these biases.
Suchmodifications might include replacing growth factors
or matrix molecules that poorly cross-react betweenmouse
and human species. A number of recently described strains,
when crossed with NBSGW,might further improve the dif-
ferentiation of human HSCs (Billerbeck et al., 2011; Brehm
et al., 2012; Rongvaux et al., 2014).
Although the main focus of our study was to grade the
relative efficiency of human HSC engraftment in a nonir-
radiated mouse model, the lack of T cell production in
NBSGW, NSGW41 and NSG warrants further discussion.
All three strains support the production of a limited num-
ber of T cells (Cosgun et al., 2014). This may be partially
due to a relatively thin thymic membrane and to the
documented poor thymic microenvironment (McDer-
mott et al., 2010; Shultz et al., 2005) for all strains.
Furthermore, in this study, we measured engraftment at
12 weeks, while T cell development is building and not
yet plateaued (Hiramatsu et al., 2003). However, the
data and reports indicate that T cell production is elevated
in the homozygous KitW41 strains in comparison to others
(Cosgun et al., 2014). In sum, these facts create an op-
portunity to improve humanized murine models via the
improvement of thymic function. Pluripotent stem cell
(PSC) technology offers one potential route to re-establish
human thymic function in humanized mouse models (Ta-
kahashi et al., 2007; Yu et al., 2007). For example, two
recent publications report the correction of a develop-
mental T cell deficiency in immunocompromised mice
(Parent et al., 2013; Sun et al., 2013). After differentiating
human embryonic stem cells to a thymic epithelial pro-
genitor cell type and grafting these cells into mice, the au-
thors produced human thymic structures capable of
further development and education of both mouse and
human T cells in vivo (Parent et al., 2013; Sun et al.,
2013). Thus, further refinements of PSC technology may
afford even better opportunities to study allogeneic and
autologous human HSC transplantation in the in vivo
mouse environment.
A variety of suitable murine xenograft models are
currently used in hematopoietic research, yet these animals
require conditioning prior to experimentation. Given the
increasingly restricted access to radiation sources, NBSGW
mice are broadly enabling, allowing laboratories without
access to radiation to accelerate human hematopoietic
research. The NBSGW model and other homozygous
mice possessing the KitW41 allele are significant steps to-
ward providing a standardized framework and an improved
understanding of human HSC biology.178 Stem Cell Reports j Vol. 4 j 171–180 j February 10, 2015 j ª2015 The AEXPERIMENTAL PROCEDURES
Animals
The C57BL/6.KitW41 and the NSG strains were obtained from
the Jackson Laboratory (Geissler et al., 1981; Shultz et al., 2005).
The NSG mouse strain was intercrossed with mice homozygous
for the KitW41 allele and the resultant progeny bred (NBSGW) to
homozygosity (for Prkdcscid, Il2rg, KitW41, SirpaNOD, TyrA). The
NBSGWmice (JAX StockNo. 026622)weremaintained as homozy-
gotes. All breeding males were retired after 1 year of age. See Sup-
plemental Experimental Procedures for oligos and allelic determi-
nation. The University of Wisconsin Medical School’s Animal
Care and Use Committee authorized all experiments.
Human Cell Engraftment
Frozen human CD34+ CBCs (AllCells) were thawed per manufac-
turer’s recommendation and incubated overnight in serum-free
media (STEMCCELL Technologies) supplemented with human
SCF (100 ng/ml; Peprotech). The next morning, live cells were
counted using a hemocytometer and trypan blue. Cells were sus-
pended at 1.25 3 106 per ml in a 10 mM HEPES buffered Hank’s
balanced salt solution (Life Technologies). Eight- to 10-week-old
male mice anesthetized with isoflurane were injected retro-orbi-
tally with 200 ml cell suspension. Serial transplants were conducted
using bone marrow cells recovered from mice engrafted with
CD34+ CBCs. Irradiation of NSG mice was carried out using an
X-RAD 320ix irradiator (Precision X-Ray) at 250 RAD.
Human Xenograft Analysis
A 50 ml blood sample was drawn into heparin-coated capillary
tubes from the retro-orbital sinus and processed for flow cytom-
teric analysis. At 12-weeks postengraftment, tissues were removed
for analysis.Multipotent progenitor analysis was performed as pre-
viously described (Majeti et al., 2007). See the Supplemental Exper-
imental Procedures for processing and antibodies. Flow cytometry
was performed on a BD AriaIII and analyzed using FlowJo Version
9.5.2 (Tree Star).
Statistics
A two-sided Wilcoxon rank-sum test was performed using the sta-
tistical software programMStat 5.5 (http://mcardle.oncology.wisc.
edu/mstat/) to determine the statistical significance between
experimental groups; n = number of experimental mice per group.
Histology and Immunohistochemistry
Tissues were fixed in 10% neutral-buffered formalin, processed at
the University of Wisconsin Veterinary School Histology Lab,
and developed as previously described (Maufort et al., 2010). Slides
were analyzed on a Zeiss AxioScope-A1 with EC Plan-NeoFluar 5
3 or 403/0.75 objectives, and images acquired using a Q-Imag-
ing Micropublisher 3.3RTV camera and iVision v.4.5.0.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental
Procedures and one table and can be found with this article online
at http://dx.doi.org/10.1016/j.stemcr.2014.12.005.uthors
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